To Demonstrate the Superiority of IMP (1% OPA-15406 Ointment) to the Vehicle in Adult Patients With AD

Clinical trial NCT05667623 · COMPLETED

Trial details

NCT number: NCT05667623
Sponsor: Otsuka Beijing Research Institute
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Atopic Dermatitis (AD)

Start date: 2023-02-06
Primary completion: 2024-06-17
Enrollment: 270

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.